Last reviewed · How we verify
NCT07315997: CAT-RA
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
trial testing high sensitivity cardiac troponin in Rheumatoid Arthritis (RA in 120 participants. Currently enrolling.
4 March 2028
Quick facts
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 4 September 2024 |
| Primary completion | 4 March 2028 |
| Estimated completion | 4 March 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- high sensitivity cardiac troponin
Conditions studied
- Rheumatoid Arthritis (RA — all drugs for Rheumatoid Arthritis (RA →
- Atherosclerotic Cardiovascular Disease (ASCVD) — all drugs for Atherosclerotic Cardiovascular Disease (ASCVD) →
Sponsor
Brigham and Women's Hospital
Who can join
Adults 35 to 79, any sex, with Rheumatoid Arthritis (RA or Atherosclerotic Cardiovascular Disease (ASCVD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Individuals with rheumatoid arthritis (RA) have up to 2x the risk of having a heart attack compared to someone without RA. The goal of this study is to identify biomarkers that can help us do a better job of identifying individuals at risk before they develop symptoms of heart disease and start preventative treatment earlier.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07315997
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis (RA
Currently open trials in the same condition.
- NCT07401732 — Dysphagia in Rheumatoid Arthritis · recruiting
- NCT07034196 — Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Car · NA · recruiting
- NCT06994143 — A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT06838884 — An Alternative Assessment in Patients with Rheumatoid Arthritis: 6 Minute Step Test · NA · recruiting
- NCT07359326 — The Effect of Cold Application in Patients With Rheumatoid Arthritis · NA · active not recruiting
Other Brigham and Women's Hospital trials
Trials by the same sponsor.
- NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
- NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
- NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
- NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
- NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07315997 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
- Last refreshed: 5 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07315997.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing